Does AGALSIDASE BETA Cause Disease progression? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Disease progression have been filed in association with AGALSIDASE BETA (Fabrazyme). This represents 1.0% of all adverse event reports for AGALSIDASE BETA.
65
Reports of Disease progression with AGALSIDASE BETA
1.0%
of all AGALSIDASE BETA reports
24
Deaths
21
Hospitalizations
How Dangerous Is Disease progression From AGALSIDASE BETA?
Of the 65 reports, 24 (36.9%) resulted in death, 21 (32.3%) required hospitalization, and 5 (7.7%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AGALSIDASE BETA. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does AGALSIDASE BETA Cause?
Malaise (409)
Pain (395)
Pyrexia (362)
Fatigue (338)
Nausea (303)
Weight decreased (272)
Headache (269)
Dyspnoea (266)
Chills (259)
Vomiting (244)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which AGALSIDASE BETA Alternatives Have Lower Disease progression Risk?
AGALSIDASE BETA vs AGOMELATINE
AGALSIDASE BETA vs ALAWAY
AGALSIDASE BETA vs ALBENDAZOLE
AGALSIDASE BETA vs ALBIGLUTIDE
AGALSIDASE BETA vs ALBUMIN